US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 1.120
  • +0.151+15.61%
Close Jul 12 16:00 ET
  • 1.070
  • -0.050-4.46%
Post 19:56 ET
38.89MMarket Cap-1898P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MiNK Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.11

+35.29%
Analyst Rating

Buy

Jun 30, 2024

MiNK Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

MiNK Therapeutics Earnings Reports

  • MiNK Therapeutics | 10-Q: Quarterly report

    May 14 07:29 ET

  • MiNK Therapeutics | 10-K: Annual report

    Mar 21 16:07 ET

  • MiNK Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 17:17 ET

  • MiNK Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 07:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.91%